| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 871.9K | $9.04M | - | |
| Other | 374.9K | $3.89M | - | |
| Other | 41.6K | $431.7K | - | |
| Other | 33.9K | $351.8K | - | |
| Other | 23.8K | $246.7K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 20, 2018 | Nathalie Adda80 | Sr. VP & Chief Medical Officer | Sale+OE | 4,155 | $92.32 | $383,596.16 | -93.1% | |
| Jul 18, 2018 | Nathalie Adda80 | Sr. VP & Chief Medical Officer | Sale+OE | 5,045 | $124.84 | $629,842.67 | -77.0% | |
| Jul 6, 2018 | Jay R. Luly71 | President and CEO | Sell | 35,000 | $125.24 | $4,383,459.58 | -5.6% | |
| Jun 18, 2018 | Nathalie Adda80 | Sr. VP & Chief Medical Officer | Sale+OE | 4,155 | $114.85 | $477,222.20 | -53.6% | |
| Jun 11, 2018 | Paul J Mellett63 | Treasurer and CFO | Sell | 15,000 | $120.57 | $1,808,523.06 | -17.0% | |
| May 17, 2018 | Jay R. Luly71 | President and CEO | Sell | 25,000 | $105.83 | $2,645,654.89 | -3.8% | |
| May 16, 2018 | Nathalie Adda80 | Sr. VP & Chief Medical Officer | Sale+OE | 4,155 | $105.25 | $437,333.12 | -46.4% | |
| Apr 16, 2018 | Nathalie Adda80 | Sr. VP & Chief Medical Officer | Sale+OE | 4,225 | $85.58 | $361,559.68 | -41.3% | |
| Mar 19, 2018 | Paul J Mellett63 | Treasurer and CFO | Sell | 9,000 | $86.48 | $778,330.51 | -9.2% | |
| Jan 4, 2017 | Yat Sun Or59 | Chief Scientific Officer | Sell | 13,921 | $35.09 | $488,504.60 | -4.4% |